COVID’s impact on cancer care and oncology research has been devastating, but the pandemic has also opened up opportunities to take learnings and create long-lasting change in research, pra
90TEN picked up the Communiqué Communications Consultancy of the Year at last night’s 2019 Communiqué Awards in London, seeing off competition from GCI, Hanover Health, In
Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.